GE HealthCare to Acquire Sofie Biosciences for $945M

GE HealthCare agreed to acquire Sofie Biosciences for $945 million to expand its reach in the U.S. radiopharmaceutical industry, gaining manufacturing and distribution capacity for F18-labeled PET products.

Why it matters. GE HealthCare's acquisition of Sofie Biosciences will enhance its capabilities in the radiopharmaceutical sector, potentially reducing bottlenecks and increasing access to radiopharmaceutical products.